I've led global clinical trials across Phases I–IV for Vectura Vertin Pharma, TRIO, IQVIA Biotech, TESARO, Pharm-Olam, and Servier.
In my current Clinical Trial Manager contract role at Vectura Vertin Pharma, I lead sponsor oversight for Phase I–II studies across countries, coordinating feasibility, site selection, EC/CA submissions, KRI tracking, vendors, budgets, and eTMF quality.
At TRIO and TESARO, I led oncology trial start-up, site activation, inspection readiness, risk assessments, and cross-functional communications while directing and mentoring regional clinical teams across Europe.
Over more than 20 years, I've managed multinational studies in 25+ countries and 50+ indications, with enrollment of up to 2,500 patients per study. I bring practical GCP-focused oversight across oncology, vaccines, cardiovascular, neurology, endocrinology, rare disease, and other therapeutic areas.
